COMP <GO>
STVN vs MMED // EV/EBITDA & P/E VALUATION
Stevanato Group S.p.A. (NYSE) VS. MiniMed Group Inc. (NASDAQ) • 15-METRIC TALLY: STVN 2
— MMED 0
■ METRIC PARITY
LAST: $19.74 (+1.86%) • MKT CAP: $5.29B
valuation
—
LAST: $18.90 (+3.39%) • MKT CAP: $5.14B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STVN VS. MMED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STVN | MMED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 54.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -3.90% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -7.75% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -6.10% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -10.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 14.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.82 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 44.5 | +1.00 | STVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.05 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 24.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.29B | $5.14B | $147.7M | STVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STVN REV | MMED REV | STVN GROSS % | MMED GROSS % | STVN FCF | MMED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $3.10B | — | 54.2% | — | -$420.0M |
| FY 2024 | — | $2.71B | — | 56.3% | — | -$53.0M |
| FY 2023 | — | $2.47B | — | — | — | -$70.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STVN // BETA —
MMED // BETA 1.05